Intrafusin

Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, the active ingredient in Intrafusin, is an amino acid supplement presented as an intravenous solution for infusion use. It is intended to support nutritional status in patients requiring parenteral amino acid provision. GNH USA supplies Intrafusin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Intrafusin is an intravenous amino acid supplement used to support metabolic and nutritional pathways in various clinical settings. - Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass. - Post‑operative recovery: provides essential substrates for tissue repair and wound healing. - Critical illness: supplies indispensable amino acids to patients receiving parenteral nutrition.

Intrafusin may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Infusion site erythema or mild pain. - Transient nausea or mild gastrointestinal discomfort. - Headache or dizziness. - Mild hyperglycemia in susceptible individuals. - Temporary electrolyte shifts (e.g., mild potassium change).

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Hyperammonemia leading to altered mental status. - Metabolic acidosis or severe electrolyte imbalance. - Acute renal dysfunction or oliguria. - Thrombophlebitis at the infusion site. - Severe hypotension or cardiovascular instability.

When using Intrafusin, clinicians should observe several safety considerations. - Assess renal function: adjust or monitor use in patients with renal impairment. - Monitor blood glucose: amino acid infusion can affect glycemic control. - Check for hypersensitivity: discontinue immediately if allergic signs appear. - Avoid in severe hepatic failure: risk of ammonia accumulation. - Pregnancy and lactation: use only if potential benefits outweigh uncertain risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Intrafusin may interact with other therapies administered concurrently.

Major Interactions (Avoid): - High‑dose parenteral lipids: increased risk of hypertriglyceridemia. - Nephrotoxic agents: may exacerbate renal stress when combined. - Ammoniagenic drugs (e.g., valproate): heightened risk of hyperammonemia.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: monitor blood glucose levels. - Electrolyte‑containing solutions: watch for cumulative electrolyte disturbances. - Loop or thiazide diuretics: may affect fluid and electrolyte balance.